Literature DB >> 1488477

Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects.

M Irwin1, U Lacher, C Caldwell.   

Abstract

Cross-sectional studies have demonstrated that natural killer (NK) cell activity is reduced in depression. To extend these observations and examine further the association between severity of depressive symptoms and values of NK activity, this study used a longitudinal case-control design and assessed NK cytotoxicity at intake and at follow-up 6 months after discharge from the hospital in depressed patients and control subjects. From acute hospitalization to follow-up, depression scores significantly (P < 0.01) decreased following treatment in the depressed patients but did not change in the control subjects. NK activity significantly (P < 0.05) increased from intake to follow-up in the depressives while lytic activity did not change in the controls. At intake NK activity was significantly (P < 0.01) reduced in the depressed patients as compared to values in the controls, while at follow-up cytotoxicity was similar between the two groups. These longitudinal data suggest that a reduction of NK cytotoxicity is temporally associated with the state of acute depression.

Entities:  

Mesh:

Year:  1992        PMID: 1488477     DOI: 10.1017/s0033291700038617

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota.

Authors:  K Takeda; T Suzuki; S-I Shimada; K Shida; M Nanno; K Okumura
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

Authors:  Tami Benton; Kevin Lynch; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David S Metzger; Joshua Blume; Steven D Douglas; Dwight L Evans
Journal:  Psychosom Med       Date:  2010-10-14       Impact factor: 4.312

4.  Immunity and depression: insomnia, retardation, and reduction of natural killer cell activity.

Authors:  H Cover; M Irwin
Journal:  J Behav Med       Date:  1994-04

5.  Immune function and health outcomes in women with depression.

Authors:  Cherie Howk; Mary Bennett
Journal:  Biopsychosoc Med       Date:  2010-05-03

6.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

7.  Isoprenoid pathway related cascade in multiple myeloma.

Authors:  Ravi kumar Kurup; Rekha A Nair; Parameswara Achutha Kurup
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

Review 8.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

9.  Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Dwight L Evans; Kevin G Lynch; Tami Benton; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David Metzger; Steven D Douglas
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

10.  Relation of depression, natural killer cell function, and infections after coronary artery bypass in women.

Authors:  Lynn V Doering; Otoniel Martínez-Maza; Donna L Vredevoe; Marie J Cowan
Journal:  Eur J Cardiovasc Nurs       Date:  2007-08-22       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.